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Over the years, the Bio-Ontologies SIG at ISMB has provided a forum for discussion
of the latest and most innovative research in the application of ontologies and more
generally the organisation, presentation and dissemination of knowledge in
biomedicine and the life sciences. The ten papers selected for this supplement are
extended versions of the original papers presented at the 2010 SIG. The papers span
a wide range of topics including practical solutions for data and knowledge
integration for translational medicine, hypothesis based querying , understanding
kidney and urinary pathways, mining the pharmacogenomics literature; theoretical
research into the orthogonality of biomedical ontologies, the representation of
diseases, the representation of research hypotheses, the combination of ontologies
and natural language processing for an annotation framework, the generation of
textual definitions, and the discovery of gene interaction networks.
Introduction and background
Ontologies are a key technology for the Semantic Web and have been widely adopted
across biomedicine in recent years. The adoption has largely been spurred due to chal-
lenges in data integration in biology and biomedicine that originate from a lack of data
standards, agreed semantics, and common vocabularies. Ontologies offer a potential
solution to this problem as they can formally define the semantics of data thereby
enabling the connection of heterogeneous data sources. Ontologies are used in the
development of new resources that integrate existing data and knowledge, annotate
experimental data, aid information retrieval, and drive literature mining.
Bio-Ontologies has been a Special Interest Group (SIG) at ISMB for the last 13 years,
providing a venue for sharing experiences and methods on the use of ontologies and
their application to life sciences. Over the years, the Bio-Ontologies SIG has provided
a forum for discussion of the latest and most innovative research in the application of
ontologies and more generally the organisation, presentation and dissemination of
knowledge in biomedicine and the life sciences. In 2010, the SIG received 27 paper
submissions, 11 flash updates and 14 poster abstracts. 17 papers and 9 flash updates
were selected for presentation at the meeting, out of which 10 papers have been
selected for this supplement.
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The ten papers selected for this supplement are extended versions of the original
papers presented at the 2010 SIG.
The papers span a wide range of topics including practical solutions for data and
knowledge integration for translational medicine [1], hypothesis based querying [3],
understanding kidney and urinary pathways [7], mining the pharmacogenomics litera-
ture [10]; theoretical research into the orthogonality of biomedical ontologies [2], the
representation of diseases [6], the representation of research hypotheses [3,9], the com-
bination of ontologies and natural language processing for an annotation framework
[4], the generation of textual definitions [5], and the discovery of gene interaction net-
works [8].
In the paper titled “The Translational Medicine Ontology and Knowledge Base: Driv-
ing personalized medicine by bridging the gap between bench and bedside” by Joanne
S. Luciano, Bosse Andersson, Colin Batchelor, Olivier Bodenreider, Tim Clark, Chris-
tine K. Denney, Christopher Domarew, Thomas Gambet, Lee Harland, Anja Jentzsch,
Vipul Kashyap, Peter Kos, Julia Kozlovsky, Timothy Lebo, M. Scott Marshall, James P.
McCusker, Deborah L. McGuinness, Chimezie Ogbuji, Elgar Pichler, Robert L. Powers,
Eric Prud’hommeaux, Matthias Samwald, Lynn Schriml, Peter J. Tonellato, Patricia L.
Whetzel, Jun Zhao, Susie Stephens, Michel Dumontier, participants in the translational
medicine task force of the World Wide Web Consortium’s Semantic Web Health Care
and Life Sciences Interest Group (W3C HCLSIG) present the Translational Medicine
Ontology (TMO) as the key component of the Translational Medicine Knowledge Base
(TMKB) [1]. The TMO and TMKB focus on clinical events such as those recorded in
an electronic medical record. The TMO provides a framework to integrate patient-cen-
tric data collected by different research communities, industries and practitioners, from
bench to bedside. The Alzheimer’s Disease use case demonstrates the advantages of
the proposed knowledge base. The project uses standard Semantic Web technologies;
the ontology is represented in OWL2, the associated knowledge base implemented in
RDF and queries are conducted using SPARQL. TMO is available at http://code.goo-
gle.com/p/translationalmedicineontology/.
The paper “How Orthogonal are the OBO Foundry Ontologies?” by Amir Ghazvi-
nian, Natalya F. Noy and Mark A. Musen reports the results of the investigation of
how the open biomedical ontologies (OBO) follow the principle of orthogonality [2].
This principle is one of the key principles a d o p t e db yt h eO B OF o u n d r y :i tr e q u i r e s
that OBO ontologies do not duplicate classes (or terms) which are already defined
within other OBO ontologies. The authors analysed orthogonality of the 6 foundry
ontologies, which conform sufficiently to the OBO Foundry principles, and the 53 can-
didate ontologies, which have commited to follow those principles. A lexical method to
find correspondences between terms in different ontologies is used. The results quan-
tify the degree of term reuse and term overlap in the OBO ontologies. The authors
also analyse how orthogonality has evolved over time. The analysis produced a list of
~10,000 current overlapping terms within the open biomedical ontologies, thus facili-
tating progress towards orthogonality. The tool for assessing the orthogonality of
ontologies is available at http://obomap.bioontology.org.
The paper “HyQue: Evaluating hypotheses using Semantic Web technologies” by Ali-
son Callahan, Michel Dumontier and Nigam Shah presents a semantic web based
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ture-sourced evidence [3]. Hypothesis validity is checked by quering knowledge bases,
inference over ontologies (for subsumption and parthood relations), and retrieval of
facts stored as Bio2RDF linked data. HyQue has been tested on the evaluation of
hypotheses of varying levels about galactose metabolism of S. cerevisiae.H y Q u e
Knowledge Base, as the core of the system, has been constructed from manually
curated S. cerevisiae gene network data and from SGD (Saccharomyces Genome Data-
base). HyQue can evaluate typical hypotheses represented as biological events. The
tool is available at http://semanticscience.org/projects/hyque
Paolo Ciccarese, Marco Ocana, Leyla Jael Garcia Castro, Sudeshna Das, and Tim
Clark in their paper “An Open Annotation Ontology for Science on Web 3.0” discuss,
in detail, a proposal for an Annotation Ontology (AO) for annotating scientific docu-
m e n t so nt h ew e b[ 4 ] .A Oi se x t e n s i b l ea n dm o dular, allowing for inclusion of other
formalisms. The authors aim to provide a sharable structure for dynamic integration of
biomedical ontologies and the literature as it emerges. AO requirements were driven
by the integration needs between biomedical web communities and biomedical text
mining. The ontology has been developed in collaboration with a number of research
groups, a major pharmaceutical company and a major scientific publisher. AO provides
a model for document metadata that can be published and shared as open linked data.
AO records associations between elements of domain ontologies represented as URIs
and online scientific content, such as scientific papers, images, etc. AO is available at
http://purl.org/ao/
Robert Stevens, James Malone, Sandra Williams, Richard Power and Allan Third in
their paper “Automating Generation of Textual Class Definitions from OWL to English”
describe a method and a prototype NLG (Natural Language Generation) method for the
automatic generation of textual definitions from logical definitions and axioms [5]. The
prototype has been tested on EFO (the Experimental Factor Ontology) and the develo-
pers of EFO have incorporated the generated definitions into the ontology. The fluency
of the generated text has been assessed through surveys. The method for the automatic
generation of definitions is effective in reducing labor intensive and time consuming
production of definitions, and supports maintenance and curation of textual definitions.
The NLG text definition tool can be found at http://swat.open.ac.uk/tools/
The paper “Scalable Representations of Diseases in Biomedical Ontologies” by Stefan
Schulz, Kent Spackman, Andrew James, Cristian Cocos and Martin Boeker suggests a
simplification of the ontological triad structure-disposition-process (SDP) suitable for
the description of pathological entities [6]. The disjunctive class pathological entity
represents diseases without specifying the ontological category. The proposed SDP
approach has been used for the redesign of events, conditions, and episodes in
SNOMED CT, where numerous diseases, processes and dispositions are ambiguous.
SDP provides an immediate working solution for ontology developers who need a con-
sistent mechanism to represent diseases.
The paper titled “Developing a Kidney and Urinary Pathway Knowledge Base” by
Simon Jupp, Julie Klein, Joost Schanstra and Robert Stevens presents KUPKB (a Kidney
and Urinary Pathway Knowledge Base) that integrates experimental findings with back-
ground knowledge [7]. The experimental data sets span multiple –omics data from
human and animal models. The KUPKB is built using Semantic Web technologies and
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(KUPO) describes the cells of the kidney in terms of their function and anatomical
locations, and provides a schema for the data held in the knowledge base. KUPKB con-
tains ~10,000,000 RDF triplets. KUPKB maybe accessed via http://www.e-lico.eu/
kupkb.
Arzucan Özgür, Zuoshuang Xiang, Dragomir R. Radev and Yongqun He in their
paper titled “Mining of vaccine-associated IFN-g gene interaction networks using the
Vaccine Ontology” show that the combination of biomedical ontologies and literature
mining facilitates the discovery of gene interactions networks [8]. In the reported
study, 186 vaccines defined in VO (the Vaccine Ontology) via the necessary and suffi-
cient conditions were used to improve the literature-based retrieval of the IFN-g and
vaccine associated gene interactions. The importance of genes has been calculated with
the use of four different types of centralities. Three gene networks have been discov-
ered where the largest one includes ~1,000 nodes. The application of VO allowed the
discovery of additional 38 genes and 60 interactions pertinent to IFN-g and vaccina-
tions. VO is available at http://www.violinet.org/vaccineontology/; and the SVM edit
kernel for gene interaction extraction is available at http://www.violinet.org/ifngvonet/
int_ext_svm.zip.
The paper “Representation of research hypotheses” by Larisa N. Soldatova, Andrey
Rzhetsky and Ross D. King describes the representation of hypotheses as logical enti-
ties suitable for automatic processing by machines [9]. It is now likely that computers
are producing the majority of hypotheses in biology, but there is still no a standardised
language for recording such hypotheses. The proposed formalism for recording
research hypotheses contributes to the development of such a standard. The formalism
enables the representation of hypotheses in an operational form so that it is possible to
design an experiment to test the hypotheses. Hypotheses can be decomposed into
more specific hypotheses or generalised to more generic ones. Hypotheses are grouped
into hypotheses sets and can be tested through cycles of investigations. The authors
also propose a framework for automatic generation of hypotheses. The proposed form-
alism for hypotheses representation is based on an ontology called LABORS, which is
available at http://www.aber.ac.uk/en/cs/research/cb/projects/robotscientist/results/
Adrien Coulet, Yael Garten, Michel Dumontier, Russ B. Altman, Mark A. Musen and
Nigam H. Shah in their paper “Integration and publication of heterogeneous text-
mined relationships on the Semantic Web” report on the PHARE (the PHArmacoge-
nomic Relationships) ontology that is used for normalizing text-extracted relationships
from the pharmacogenomics literature [10]. PHARE has been constructed semi-auto-
matically. First, over 40,000 relations have been automatically extracted from MED-
LINE abstracts, which link key entities (genes, drugs, and phenotypes) as well as
modified or composite entities, such as drug effect or disease treatment. 41 genes high-
lighted by PharmGB, 3,007 drugs, and 4,202 phenotypes are used in the mining pro-
cess to extract relationships they participate in. Secondly, a normalised set of 229 most
frequent relations and 76 roles was identified by manual curation. The normalised rela-
tionships have been used to instantiate ~30,000 roles encoded as RDF triplets and are
available for use on the Semantic Web: http://sparql.bioontology.org/webui/. The
PHARE ontology is available at http://bioportal.bioontology.org/ontologies/45138
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